anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

List

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 110,471
Current window 76,081-76,110
Pages 3,683
Rows per page 30
Component: Listclear collectionreset all
18 30 60

Component

76,081-76,110 of 110,471

filter-aware
57
Peloton | Investor Day Presentation Deck | 71 slidesPeloton | Investor Day Presentation Deck | 71 slides · Peloton
Conference presentation Investor relations Beat · Action1 hit
59
Peloton | Investor Day Presentation Deck | 71 slidesPeloton | Investor Day Presentation Deck | 71 slides · Peloton
Conference presentation Investor relations Beat · Action1 hit
61
Peloton | Investor Day Presentation Deck | 71 slidesPeloton | Investor Day Presentation Deck | 71 slides · Peloton
Conference presentation Investor relations Beat · Action1 hit
64
Uses a funnel diagram to visualize market segmentation.Peloton | Investor Day Presentation Deck | 71 slides · Peloton
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
69
The chart uses a combination of bar (subscriptions) and line (margin) to show the trade-off between growth and profitability.Peloton | Investor Day Presentation Deck | 71 slides · Peloton
Conference presentation Investor relations Beat · ActionLoop · Cost Of Inaction1 hit
04
The table highlights significant revenue declines across all channels due to the 2020 pandemic impact.Salvatore Ferragamo | Results Presentation Deck | 10 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · EvidenceLoop · Benchmark Gap1 hit
05
The table highlights significant revenue declines across all regions due to the 2020 market environment.Salvatore Ferragamo | Results Presentation Deck | 10 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · EvidenceLoop · Benchmark Gap1 hit
06
The table highlights significant revenue declines across all categories, with Shoes and Leather Goods & Handbags being the primary contributors to total turnover.Salvatore Ferragamo | Results Presentation Deck | 10 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · EvidenceLoop · So What Cascade1 hit
08
Includes IFRS16 impact adjustments.Salvatore Ferragamo | Results Presentation Deck | 10 slides · Salvatore Ferragamo
Conference presentation Investor relations Beat · Resolution1 hit
13
The slide uses a grid of icons to represent platform capabilities alongside isometric game tile illustrations.Skillz | SPAC Presentation Deck | 42 slides · Skillz
Pitch deck Investment bank Beat · Solution1 hit
25
Uses a contrast-pair framework to illustrate market friction.Skillz | SPAC Presentation Deck | 42 slides · Skillz
Pitch deck Investment bank 1 hit
27
The slide highlights 8 core service pillars alongside a UI screenshot of the platform.Skillz | SPAC Presentation Deck | 42 slides · Skillz
Pitch deck Investment bank 1 hit
28
The chart compares Skillz ($6.30) to the average of ZNGA and GLUU ($1.70).Skillz | SPAC Presentation Deck | 42 slides · Skillz
Pitch deck Investment bank Loop · Mece Breakdown1 hit
34
The diagram uses a nested circle approach to show additive market opportunities.Skillz | SPAC Presentation Deck | 42 slides · Skillz
Pitch deck Investment bank Beat · Satisfaction1 hit
35
Slide 33 of the pitch deck.Skillz | SPAC Presentation Deck | 42 slides · Skillz
Pitch deck Investment bank 1 hit
41
Includes a visual comparison of skill vs chance via scatter plots and a logo grid of compliance partners.Skillz | SPAC Presentation Deck | 42 slides · Skillz
Pitch deck Investment bank 1 hit
16
Includes a biological pathway diagram and a clinical progression timeline.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Logic Chain1 hit
17
The chart uses a sigmoid-like curve to show the relationship between enzyme activity and disease progression.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Logic Chain1 hit
21
The chart displays statistical significance markers (asterisks) comparing treatment groups to the vehicle control.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Logic Chain1 hit
23
Includes a diagram of the AAV9-hCLN1 gene therapy construct.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Desire1 hit
25
The chart compares untreated WT, Het, and KO mice against treated mice at 4, 20, and 26 weeks of age.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Desire1 hit
26
The slide uses a consistent icon for each pipeline entry.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Desire1 hit
28
Includes a citation for disease reversibility research.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Aha Moment1 hit
29
Includes a visual spectrum diagram showing the relationship between MECP2 expression levels and clinical outcomes.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Aha Moment1 hit
30
The slide uses a diagram to illustrate the genetic construct (scAAV ITR, MeP426, miniMECP2, miRARE).Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · DesireLoop · Aha Moment1 hit
35
The slide compares TSHA-102 against control and other AAV9 constructs. The bottom box highlights specific adverse event rates (lesions/prolapses).Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · ActionLoop · Aha Moment1 hit
38
The slide uses a consistent structure for each pipeline asset: program name, target indication, development stage, disease description, and prevalence.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
46
The diagram illustrates a molecular biology workflow for AAV capsid engineering.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
47
The slide highlights the potential to bypass immune responses for gene therapy redosing.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit
50
The slide outlines a specific R&D process (Reg1 and MiRARE) for gene therapy target identification.Taysha | IPO Presentation Deck | 66 slides · Taysha Gene Therapies
Pitch deck Investment bank Beat · Action1 hit